CRISPR Therapeutics, Inc Technographics
CRISPR Therapeutics, Inc Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by CRISPR Therapeutics, Inc and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 458 CRISPR Therapeutics, Inc employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that CRISPR Therapeutics, Inc has purchased the following applications: Oracle Cloud ERP for ERP Financial in 2018, Rocket.chat for Chatbots and Conversational AI in 2018, Microsoft 365 for Collaboration in 2015 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems CRISPR Therapeutics, Inc is running and its propensity to invest more and deepen its relationship with Oracle , Rocket.chat , Microsoft or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing CRISPR Therapeutics, Inc revenues, which have grown to $439.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for CRISPR Therapeutics, Inc intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
CRISPR Therapeutics, Inc Tech Stack and Enterprise Applications
CRISPR Therapeutics, Inc ERP
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Oracle | Legacy | Oracle Cloud ERP | ERP Financial | ERP | n/a | 2018 | 2019 |
In 2018, CRISPR Therapeutics, Inc implemented Oracle Cloud ERP in an ERP Financial deployment to centralize corporate accounting, general ledger and consolidation for the finance organization. The implementation targeted the Finance group and a global consolidating environment, supporting accounting for international operations, intercompany transactions and inventory accounting activities.
Oracle Cloud ERP was configured to support core financial modules including general ledger, journal entry processing, balance sheet reconciliations and month end close orchestration. Functional configuration emphasized inventory accounting flows, intercompany accounting rules and schedule generation to support quarterly and annual financial audits, aligning system workflows with GAAP accounting responsibilities.
Operational workflows connected Oracle Cloud ERP to FP&A collaboration for post close variance analysis and to audit preparation through structured schedule and document outputs. Day to day activities required finance personnel to prepare and process journal entries into Oracle Fusion as the operational ledger interface, while the system supported consolidations and cross border accounting procedures across corporate finance and accounting functions.
Governance around the deployment reinforced month end close ownership, standardized reconciliation schedules and strengthened internal control processes, with the Sr. Manager Accounting and Sr. Director Finance owning process design. The implementation also built in capacity for ad hoc projects and workflow process improvements to sustain finance controls, audit readiness and ongoing liaison between accounting and FP&A.
|
CRISPR Therapeutics, Inc AI-Powered Application
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Rocket.chat | Legacy | Rocket.chat | Chatbots and Conversational AI | AI-Powered Application | n/a | 2018 | 2018 |
In 2018 CRISPR Therapeutics, Inc deployed Rocket.chat as a web-embedded conversational interface within the Chatbots and Conversational AI category. Rocket.chat is present on the corporate website to provide a real-time messaging channel for site visitors and external stakeholders, implemented as an embeddable browser client that surfaces conversational interactions directly on public pages.
Functional capabilities implemented with Rocket.chat include a web chat widget, real-time messaging, channel-based routing, and administrative moderation and configuration, consistent with standard Chatbots and Conversational AI workflows. Operational scope is focused on public facing website engagement, with the platform positioned to capture external inquiries and route conversations to internal teams, and governance administered through Rocket.chat configuration and moderation controls supporting conversation management on the CRISPR Therapeutics, Inc website.
|
CRISPR Therapeutics, Inc Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2015 | 2015 |
In 2015, CRISPR Therapeutics, Inc implemented Microsoft 365 as a Collaboration platform. The corporate website references Microsoft 365 assets, indicating organization-wide use of cloud-hosted productivity services and public-facing integration points for content and collaboration.
The Microsoft 365 deployment centers on cloud tenant architecture and provides core Collaboration capabilities including Exchange Online email, SharePoint Online document management, OneDrive for Business file sync, and Microsoft Teams for synchronous and asynchronous collaboration. Governance and access controls align with centralized identity and access management and role-based permissions, supporting research, corporate operations, and administrative functions through integrated messaging, document management, and team collaboration workflows.
|
CRISPR Therapeutics, Inc Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application, Web and Enterprise Search | Content Management |
|
2020 | 2020 |
|
|
|
|
|
Digital Signing | Content Management |
|
2021 | 2021 |
|
|
|
|
|
Web Content Management | Content Management |
|
2018 | 2018 |
|
CRISPR Therapeutics, Inc CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Customer Experience | CRM |
|
2020 | 2020 |
|
CRISPR Therapeutics, Inc Procurement
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Procurement | Procurement |
|
2018 | 2018 |
|
CRISPR Therapeutics, Inc IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2014 | 2014 |
|
CRISPR Therapeutics, Inc CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Identity and Access Management (IAM) | CyberSecurity |
|
2021 | 2021 |
|
|
|
|
|
Secure Email Gateways (SEGs) | CyberSecurity |
|
2018 | 2018 |
|
IT Decision Makers and Key Stakeholders at CRISPR Therapeutics, Inc
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by CRISPR Therapeutics, Inc Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||